ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 750035 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 750035; 2) Community: the network communities that were significantly associated with the response to NSC 750035; 3) Molecule: the relationships between components within communities and NSC 750035; 4) MDR: the compounds that were significantly associated with the NSC 750035.

NSC Compound Enrichment Correlation
NSC 633685 9-N-(N'-chloroethyl-N'-1,6-diaminohexyl) 2-methoxyacridine, dihydrochloride 0.00356914129105574 0.31202313
NSC 656206 Discorhabdin I 0.00356914129105574 0.41466905
NSC 666112 Null 0.00356914129105574 0.64691374
NSC 683086 Boronic acid, [3-methyl-1-[[1-oxo-4-phenyl- 2-[[(2-quinolinyl)carbonyl]amino]butyl]amino]butyl]- 0.00356914129105574 0.40892744
NSC 689735 Null 0.00356914129105574 0.35420705
NSC 705331 2-Propenamide, N-(1,1-dimethylethyl)-N-(phenylmethyl)- 3-(phenylsulfinyl)-, (2Z)- 0.00356914129105574 0.55290307
NSC 758881 Orlistat (USAN) 0.00356914129105577 0.10828758
NSC 84074 Phosphonium, (3-bromopropyl)triphenyl- bromide 0.00356914129105577 0.49253863
NSC 302035 Melampodin B acetate 0.00385572727186006 0.64168022
NSC 619042 Cyclohexanone, 2,6-bis[(dimethylamino)methyl]-, dihydrochloride 0.00385572727186006 0.61788689
Total:108  Current:12    [First] [Prev] [Next] [Last]